CVRx, Inc. CVRX
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-30
CVRx, Inc. statistics & valuation
Market cap$155.5M
P / S2.7×
P / B4.0×
Net margin-94.1%
Return on equity-135.6%
FCF margin-71.9%
Net cash$26.2M
Enterprise value USD$129.3M
Earnings yield EBIT/EV-39.6%
Return on capital-56%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% | 76.2% |
| Operating margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | -190.2% |
| Net margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.5% | -233.1% |
| FCF margin | -71.9% | -79.0% | -100.8% | -193.0% | -221.8% | -271.1% |
| Return on assets | -50.9% | -44.9% | -35.8% | -33.2% | -28.2% | -21.8% |
| Return on equity | -135.6% | -84.4% | -54.2% | -37.9% | -29.5% | 4.8% |
| Debt / equity | 1.26× | 0.69× | 0.38× | 0.06× | 0.00× | -0.07× |
| Current ratio | 7.63 | 12.06 | 14.25 | 15.19 | 25.57 | 8.07 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.